Trial Profile
Prospective study evaluating the safety and efficacy of new regimen of Topotecan. Ifosfamide, Etoposide and L-Asparaginase (TIEL) in patients with T-cell lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Asparaginase (Primary) ; Etoposide (Primary) ; Ifosfamide (Primary) ; Topotecan (Primary)
- Indications T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2016 New trial record